Richard Auburn
Direktor/Vorstandsmitglied bei Singula Bio Ltd.
Aktive Positionen von Richard Auburn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01.01.2015 | - |
Singula Bio Ltd.
 Singula Bio Ltd. BiotechnologyHealth Technology Singula Bio Ltd. is a seed-stage biotechnology company based in Oxford, UK. The British company was spun out of the University of Oxford and is focused on developing novel neoantigen-based cell therapies for patients with solid tumors. The company was founded by Vincenzo Cerundolo, Enda McVeigh, Ahmed Ahmed. | Direktor/Vorstandsmitglied | 01.11.2020 | - |
Karriereverlauf von Richard Auburn
Ausbildung von Richard Auburn
| University of Cambridge | Graduate Degree |
| University of Aberdeen | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 5 |
Operativ
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Finance |
Singula Bio Ltd.
Singula Bio Ltd. BiotechnologyHealth Technology Singula Bio Ltd. is a seed-stage biotechnology company based in Oxford, UK. The British company was spun out of the University of Oxford and is focused on developing novel neoantigen-based cell therapies for patients with solid tumors. The company was founded by Vincenzo Cerundolo, Enda McVeigh, Ahmed Ahmed. | Health Technology |
- Börse
- Insiders
- Richard Auburn
- Erfahrung